Cargando…

Azithromycin and the microbiota of cystic fibrosis sputum

BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acosta, Nicole, Thornton, Christina S., Surette, Michael G., Somayaji, Ranjani, Rossi, Laura, Rabin, Harvey R., Parkins, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008652/ https://www.ncbi.nlm.nih.gov/pubmed/33784986 http://dx.doi.org/10.1186/s12866-021-02159-5

Ejemplares similares

Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
por: Lam, John C, et al.
Publicado: (2015)

Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis
por: Skolnik, Kate, et al.
Publicado: (2015)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)

Stenotrophomonas maltophilia natural history and evolution in the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2023)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
por: Heirali, Alya A., et al.
Publicado: (2017)

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
por: Whelan, Fiona J., et al.
Publicado: (2017)

Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
por: Thornton, Christina S, et al.
Publicado: (2022)

The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2022)

Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission
por: Izydorczyk, Conrad, et al.
Publicado: (2020)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
por: Somayaji, R., et al.
Publicado: (2015)

Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
por: Somayaji, R., et al.
Publicado: (2015)

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
por: Woo, T. E., et al.
Publicado: (2019)

Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
por: Nichols, Dave P., et al.
Publicado: (2020)

Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis
por: Thornton, Christina S., et al.
Publicado: (2022)

Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
por: Sibley, Christopher D., et al.
Publicado: (2011)

Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study
por: Thornton, Christina S, et al.
Publicado: (2015)

Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
por: Edwards, B D, et al.
Publicado: (2019)

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
por: Workentine, Matthew L., et al.
Publicado: (2013)

Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
por: Heirali, Alya, et al.
Publicado: (2016)

Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
por: Skolnik, Kate, et al.
Publicado: (2017)

Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis
por: Patel, Premal, et al.
Publicado: (2013)

Single nucleotide variants in Pseudomonas aeruginosa populations from sputum correlate with baseline lung function and predict disease progression in individuals with cystic fibrosis
por: Saber, Morteza M., et al.
Publicado: (2023)

Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis
por: Horsley, Alex, et al.
Publicado: (2014)

Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis
por: Duong, Jessica, et al.
Publicado: (2015)

Incidence and Outcomes of Endophthalmitis Associated Hospitalizations in Children Aged ≤ 20 Years: A Population-Based Cohort Study
por: Edwards, Brett, et al.
Publicado: (2017)

Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis
por: Nielsen, Bibi Uhre, et al.
Publicado: (2020)

The effect of azithromycin on sputum inflammatory markers in bronchiectasis
por: Terpstra, L. C., et al.
Publicado: (2023)

Cystic fibrosis physicians’ perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States
por: Ramos, Kathleen J., et al.
Publicado: (2017)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
por: Kumar, Sheemal Shanista, et al.
Publicado: (2019)

Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis
por: Liou, Theodore G., et al.
Publicado: (2012)

An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum
por: Graf, Alexander C., et al.
Publicado: (2021)

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA
por: Grahl, Nora, et al.
Publicado: (2018)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

The Inhibition of Superoxide Production by the Soluble Phase of Cystic Fibrosis Sputum
por: Dosanjh, Amrita
Publicado: (2008)

Isolation and characterization of microparticles in sputum from cystic fibrosis patients
por: Porro, Chiara, et al.
Publicado: (2010)

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome
por: Quinn, Robert A, et al.
Publicado: (2016)

Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis
por: Breen, Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8reo5367536q5si38p8mla4b9p